Finance

Chinese biotech company releases financials, shows sales increase of 110%

Published in Biotech Business Week, December 20th, 2004

Sinovac Biotech Ltd. (SNVBF) has released financial statements for the first 6 months of 2004 in a Form 6-K filing with the SEC on November 12, 2004, in support of its AMEX listing application.

The updated financial statements cover company business activities to the end of June 2004, during which Sinovac sales increased by 110% over the first 6 months of 2003.

Sales revenue is attributed to Healive, the only product of the company that is currently available in the market. The sales of this product increased from $1,090,856 for the first half of 2003 to $2,291,558 of the corresponding period of this year, equivalent to a 110% increase. The company...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-12-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry